STOCK TITAN
  1. Home
  2. GRPH

Graphite (GRPH) Stock Price, News & Analysis

GRPH NASDAQ

Company Description

Graphite (NASDAQ: GRPH) is classified in the research and development in biotechnology industry within the Professional, Scientific, and Technical Services sector.

This page collects what Stock Titan holds for GRPH, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
199.9M
Shares outstanding

Latest News

View All
+18.79%

Graphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz Therapeutics

dividends acquisition
-3.43%

LENZ Therapeutics and Graphite Bio Announce Merger Agreement

acquisition
+1.28%

Healthpeak Properties Reports Third Quarter 2023 Results and Declares Quarterly Cash Dividend on Common Stock

dividends earnings
-3.62%

Graphite Bio Announces Departure of Chief Financial Officer

-4.12%

Graphite Bio Reports Recent Business Progress and Fourth Quarter and Fiscal Year 2022 Financial Results

earnings
+15.91%

Graphite Bio Announces Process to Explore Strategic Alternatives and Corporate Restructuring

Graphite has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include dividends, acquisition, earnings, clinical trial. View all GRPH news →

SEC Filings

View All

No SEC filings available for GRPH.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

GRPH Company Profile & Sector Positioning

Graphite (GRPH) operates in the Research and Development in Biotechnology industry within the broader Professional, Scientific, and Technical Services sector and is listed on the NASDAQ.